MoBiTec GmbH

MoBiTec to Offer New Transcreener UDP2 TR-FRET Assay, Manufactured by BellBrook Labs

Just like the existing UDP2 FP assay, the TR-FRET assay provides sensitive detection of glycosyltransferases and other UDP-producing enzymes. The new Transcreener UDP2 TR-FRET Assay will better serve a growing need for robust, HTS-proven glycosyltransferase assays for drug discovery.

Goettingen, Germany, January 31, 2015 --( The Transcreener UDP2 Assay is a single step, homogenous, fluorescent assay for detection and screening of UDP-producing enzymes. Direct detection of UDP with a fluorescence polarization (FP) readout provides a safe, HTS-compatible alternative to cumbersome radioassay methods and is more sensitive and less subject to interference than coupled assay methods, where the UDP is converted to another product. Based on BellBrook's proprietary nucleotide immunodetection technology, the Transcreener UDP2 Assay is compatible with any enzyme class that produces UDP, including UDP-glucose-, UDP-galactose- and UDP-glucuronosyl-transferases as well as glycogen, hyaluranon and cellulose synthases.

Robust, HTS-Compatible Assay

• Simple, “mix and read” assay format.
• Far red fluorescence minimizes interference.
• Outstanding deck and signal stability.
• Compatible with any multimode plate reader.

More Sensitive

New antibody provides greater sensitivity than original Transcreener UDP Assay: excellent signal and Z’ using less than 1μM UDP-sugar.

Customers from Europe are welcome to visit or contact MoBiTec GmbH for Transcreener® Assay product pricing. Custom quotes are available for bulk orders.

About Bellbrook Labs

BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, BBL identifies areas where there is a strong need but a significant technical hurdle, and then BBL develops a solution. The company is focused on taking creative approaches to new product development and to continually improving the level of service provided to our customers. BellBrook is undergoing a big change with the launch of the first two iuvo™ products and the Invasion Assay Service in 2010. The company has built its reputation on Transcreener®, a biochemical assay platform, and with iuvo BBL is introducing completely new way to perform cellular assays.

About MoBiTec GmbH

MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.
MoBiTec GmbH
Arne Schulz